CME Group (NASDAQ:CME) Given New $231.00 Price Target at Barclays

CME Group (NASDAQ:CME) had its price target increased by Barclays from $219.00 to $231.00 in a report published on Thursday, Benzinga reports. The firm currently has an equal weight rating on the financial services provider’s stock.

A number of other research firms have also recently commented on CME. Bank of America lifted their price target on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Citigroup raised their price target on shares of CME Group from $240.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. Morgan Stanley boosted their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Piper Sandler upped their target price on shares of CME Group from $225.00 to $240.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, CME Group has an average rating of “Hold” and an average target price of $222.07.

CME Group Trading Down 0.7 %

Shares of NASDAQ:CME traded down $1.62 during trading on Thursday, reaching $228.07. The stock had a trading volume of 61,043 shares, compared to its average volume of 1,926,543. The stock has a market cap of $82.12 billion, a price-to-earnings ratio of 26.13, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group has a 52 week low of $190.70 and a 52 week high of $230.36. The firm’s fifty day moving average is $218.08 and its 200 day moving average is $208.66. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.25 EPS. As a group, equities analysts forecast that CME Group will post 10.04 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.02%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Insider Activity at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On CME Group

Hedge funds have recently made changes to their positions in the business. Oak Harvest Investment Services increased its holdings in CME Group by 66.5% in the 1st quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock valued at $9,708,000 after acquiring an additional 18,017 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in shares of CME Group by 21.2% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after buying an additional 8,443 shares in the last quarter. Duality Advisers LP bought a new position in CME Group during the first quarter valued at approximately $1,455,000. SG Americas Securities LLC grew its holdings in CME Group by 312.2% during the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock valued at $12,222,000 after buying an additional 42,996 shares in the last quarter. Finally, Cetera Investment Advisers raised its holdings in shares of CME Group by 429.1% during the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after acquiring an additional 38,540 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.